MDxHealth Overview
- Founded
-
2003
- Status
-
Public
- Employees
-
236
- Stock Symbol
-
MDXH
- Investments
-
4
- Share Price
-
$0.28
- (As of Friday Closing)
MDxHealth General Information
Description
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.
Contact Information
- 15279 Alton Parkway
- Suite 100
- Irvine, CA 92618
- United States
MDxHealth Timeline
MDxHealth Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.28 | $0.28 | $0.27 - $0.81 | 270M | 460K | -$0.24 |
MDxHealth Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 82,124 | 78,172 | 139,573 | 86,330 |
| Revenue | 55,490 | 37,054 | 22,239 | 18,460 |
| EBITDA | (37,369) | (36,624) | (24,102) | (23,984) |
| Net Income | (48,275) | (44,044) | (29,002) | (28,662) |
| Total Assets | 142,545 | 119,135 | 75,072 | 31,856 |
| Total Debt | 40,589 | 39,793 | 15,556 | 15,871 |
MDxHealth Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MDxHealth Comparisons
Industry
Financing
Details
00000
0000 0
MDxHealth Competitors (5)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Caris Life Sciences | Private Equity-Backed | Irving, TX | 0000 | 00.00 | 000000000 00 | 00.00 |
| 0000 00 0000 | Formerly Accelerator/Incubator backed | Houston, TX | 00 | 000000&0 | ||
| 00000 00000000 | Corporate Backed or Acquired | Aliso Viejo, CA | 000 | 000000&0 | ||
| 00000 000000000000 | Formerly VC-backed | San Diego, CA | 00 | 00000 | 00000000 | 00000 |
| 0000000 | Formerly VC-backed | Buffalo, NY | 00 | 000.00 | 000000&0 | 000.00 |
MDxHealth Patents
MDxHealth Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3596236-A1 | Mgmt epigenetic deep-sequencing assay | Active | 17-Mar-2017 | 0000000000 | |
| EP-3596236-B1 | Mgmt epigenetic deep-sequencing assay | Active | 17-Mar-2017 | 0000000000 | |
| US-20200010907-A1 | Mgmt epigenetic deep-sequencing assay | Pending | 17-Mar-2017 | 0000000000 | |
| EP-3580357-B1 | Algorithms and methods for assessing late clinical endpoints in prostate cancer | Active | 13-Feb-2017 | 0000000000 | |
| EP-3580357-A1 | Algorithms and methods for assessing late clinical endpoints in prostate cancer | Active | 13-Feb-2017 | C12Q1/6886 |
MDxHealth Executive Team (26)
MDxHealth Board Members (14)
| Name | Representing | Role | Since |
|---|---|---|---|
| Donnie Hardison | Self | Board Member | 000 0000 |
| Hilde Windels | Self | Board Member | 000 0000 |
| Koen Hoffman | Self | Chairman & Board Member | 000 0000 |
| Lieve Verplancke MD | Self | Board Member | 000 0000 |
| Michael McGarrity | MDxHealth | Chief Executive Officer & Board Member | 000 0000 |
MDxHealth Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
MDxHealth Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MDxHealth Investments & Acquisitions (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 0000000 | 07-Mar-2022 | 0000000000 | 00000 | Diagnostic Equipment | 0000000 0 |
| 00000000000 | 18-Sep-2015 | 0000000000 | 00.00 | Laboratory Services (Healthcare) | 000 00000 |
| 000000000 000 | 12-Aug-2008 | 00000 0000 | 00.000 | Biotechnology | |
| Signature Diagnostics | 30-Jan-2008 | Early Stage VC | Biotechnology |
MDxHealth ESG
Risk Overview
Risk Rating
Updated December, 21, 2022
28.42 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,491
Rank
Percentile
Pharmaceuticals
Industry
00 of 871
Rank
Percentile
Biotechnology
Subindustry
00 of 389
Rank
Percentile
MDxHealth Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000000 00000000 | 12-Aug-2008 | 00000 00000 00 | 00.000 | Completed |
|
| Signature Diagnostics | 30-Jan-2008 | Early Stage VC | Completed |